Express Press Release Distribution

Accounting
Advertising
Aerospace
Agriculture
Apparel & Fashion
Automotive
Biotech
Chemicals
Computers
Construction
Consumer Services
Defense
Education
Electronics
Energy
Entertainment
Environment
Financial
Food & Beverage
Government
Healthcare
Human Resources
Industrial
International Trade
Internet & Online
Law
Management
Marketing
Media
Non Profit
Pharmaceuticals
Real Estate
Retail
Semiconductors
Small Business
Software
Sports
Telecommunications
Transportation / Logistics
Travel

EPR Archived News

Archived News 2012
~ April
~ March
~ February
~ January

Archived News 2011
~ December
~ November
~ October
~ September
~ August
~ July
~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2010
Archived News 2009
Archived News 2008
Archived News 2007
Archived News 2006
Archived News 2005
Archived News 2004

 

PREMIER Biosoft International Releases TMA Foresight, a Statistical Tool for Tissue Microarray Data Analysis

Released on = January 16, 2007, 10:31 am

Press Release Author = Neil Watson

Industry = Biotech

Press Release Summary = TMA Foresight is a statistical tool for tissue microarray
data analysis designed especially for pathologists, clinicians and researchers

Press Release Body = Palo Alto, California -- January 15, 2007, PREMIER Biosoft
International today announced the release of its new product, TMA Foresight. TMA
Foresight is a statistical tool for tissue microarray data analysis designed
especially for pathologists, clinicians and researchers.
TMA Foresight can be used for a wide variety of analysis ranging from simple
descriptive statistics that include mean, sum, and variance to more advanced data
correlation such as Hierarchical clustering and Kaplan Meier plots. You can explore
the relatedness of prognostic marker expression and clinico-pathological variates
with the outcome. Cox\'s Proportional Hazard analysis can be used for prognostic
marker identification. Hierarchical clustering can be used to group patients on the
basis of a clinico-pathological parameter or a biomarker. Kaplan-Meier plots and
log-rank tests can then be used to identify prognostically significant clusters. You
can threshold a particular marker and stratify patients into high risk and low risk
cohorts.
TMA Foresight enables easy data pre-processing. It helps map the character data to
numeric values with a click of a button. Moreover, the measurement level of each
variable can be conveniently defined for use in different statistical analysis.
Says Kay Brown, V.P. Business Development and Marketing, \"The tissue microarray
market, is predicted to grow at 42% per year to over $163 million by 2008. We have
designed TMA Foresight seeing the need for an easy-to-use specialized data analysis
software tool.\"
Please visit the PREMIER Biosoft web site (www.premierbiosoft.com) to experience
what TMA Foresight can do for you.
About PREMIER Biosoft International:
Founded in 1994, the company is a group of computer scientists and molecular
biologists dedicated to producing cutting edge intuitive software for the molecular
biologist. The goal of the company is to study the most recent innovations in
molecular biology and translate them into software products that aid biologists.
Additional information about PREMIER Biosoft International can be found at
http://www.PremierBiosoft.com
Contact:
Arun Apte
PREMIER Biosoft International
(650) 856-2703
http://www.PremierBiosoft.com


Web Site = http://www.premierbiosoft.com

Contact Details = PREMIER Biosoft International
3786 Corina Way
Palo Alto, CA 94303-4504
Phone: 650-856-2703
Fax: 650-618-1773
Email: support@premierbiosoft.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •